Rule · SMV · 27 May 2020
Issuing companies with securities registered in the RPMV that prepare financial information under IFRS must evaluate going-concern uncertainties, impairment of non-financial assets, goodwill and intangibles annually, expected credit losses, onerous contracts, lease modifications, subsequent events and interim changes, and disclose material COVID-19 impacts in their financial statements and Management Report under item 10.002 of the Manual for the Preparation of Financial Information.
Miraflores, 27 May 2020
Dear Sirs
Present.-
Ref.: File No. 2020017881
I address you in relation to (i) the exceptional situation that has arisen from the COVID-19 pandemic, the declaration of the National State of Emergency decreed by the Executive Branch, mandatory social isolation (lockdown), border closures, and the partial or total paralysis of economic activities, among others, and (ii) the significant uncertainties that have been generated in securities issuers as a consequence of said situation regarding aspects such as current and expected profitability, compliance with payment commitments and potential sources of financing, which may affect the financial situation, financial performance and cash flows or influence the company's ability to continue as a going concern.
In this regard, considering the foregoing paragraph, Circular No. 140-2020-SMV/11.1 has been issued to all securities issuers, through which the document entitled "Impact of the pandemic and COVID-19 crisis on the Financial Statements of companies with securities registered in the Public Registry of the Securities Market – Main considerations and recommendations in risk assessment, measurements, estimates and disclosures of financial statements prepared under IFRS" has been sent to them, the content of which is related to the relevant aspects that said issuers must consider in the preparation of financial information in accordance with International Financial Reporting Standards – IFRS.
In this framework, and considering the obligation set forth in subsection g) of article 24 of the Regulation on Primary Public Offering and Sale of Securities, approved by CONASEV Resolution No. 141-98-EF-94.10 and its amending norms, in accordance with literal g) of Section Three of the Manual for Compliance with the Requirements Applicable to Public Offers of Securities, approved by General Management Resolution No. 211-98-EF/94.11, regarding the quarterly submission of a report on compliance with the conditions of the issuance, of the securities of your represented company, as well as the submission of such information where there are modifications in the conditions of the issuance —a document that must be submitted within five (05) business days following the submission of the issuer's individual interim financial information to the SMV—, as well as its duty to safeguard the interests of bondholders as its own, as provided in article 92 of the Securities Market Law, Legislative Decree No. 861 and its amending norms, a copy of Circular No. 140-2020-SMV/11.1 and its attached document is sent to you as an instrument that assists and reinforces the performance of your duties in complying with the aforementioned duty.
PERU Ministry of Economy and Finance
SMV
Superintendency of the Market in Securities
DECADE OF EQUAL OPPORTUNITIES FOR WOMEN AND MEN -YEAR OF UNIVERSALIZATION OF HEALTH
Without any other particular, I remain yours.
Sincerely,
Reason:
Signed by: GODOS GARCIA Alix Fernando FAU 2013101
Alix Godos
General Intendant
General Intendancy of Conduct Supervision
Miraflores, 25 May 2020
Dear Sirs
Present.-
Ref.: File No. 2020017536
Circulars No. 337 and 338-2019-SMV/11
I address you in relation to the financial statements that companies with securities registered in the Public Registry of the Securities Market – RPMV disseminate to the market, in compliance with the regulatory requirements established in SMV Resolution No. 016-2015-SMV/01 and its amending norms, and with the purpose of providing information on the financial situation, financial performance and cash flows, necessary for the duly informed decision-making of investors and the various participants of the securities market.
In this regard, based on the provisions of articles 10, 13 and 30 of the Securities Market Law, Legislative Decree No. 861 and its amending norms, and the norm cited in the preceding paragraph, it is necessary to inform you that, given the pandemic and COVID-19 crisis, the Superintendency of the Securities Market – SMV considers it necessary to remind you and emphasize that your represented company must adopt the necessary measures and actions so that in the preparation of its financial statements the International Financial Reporting Standards issued by the International Accounting Standards Board – IASB and internationally in force (hereinafter, IFRS) are fully observed.
As you are aware, compliance with IFRS implies fully meeting the requirements for recognition, measurement, presentation and disclosure on economic transactions and events that are important for the financial information disseminated to the market, in such a way as to ensure that said information complies with the standards of quality, veracity, sufficiency and timeliness.
Likewise, it should be noted that in the responses to the referenced circulars your represented company informed the market about various aspects related to the preparation of its financial statements and the related internal control and risk management system.
In that line of reasoning, due to the exceptional situation generated by the COVID-19 pandemic, the SMV has considered it necessary to prepare the attached document entitled «Impact of the pandemic and crisis caused by COVID-19 on the Financial Statements of companies with securities registered in the Public Registry of the Securities Market – Main considerations and recommendations in the evaluation of risks, in the measurements, estimates and disclosures of financial statements prepared according to IFRS», and to notify it to you through this circular, so that it serves as a guide for your represented company on the points of interest that, in the SMV's opinion, should be of concern to your company and its governing bodies regarding the main accounting aspects and matters that must be considered when preparing its financial statements.
It should be noted that although said document has been formulated as recommendations, it must be kept in mind that it essentially reflects what IFRS and the applicable regulatory framework establish, so the emphases detailed therein must be evaluated and applied, as appropriate, in the next financial statements to be disclosed to the market by your represented company.
Without further particular, I remain yours.
Sincerely,
Alix Godos
General Superintendent
General Superintendence of Conduct Supervision
PERU Ministry of Economy and Finance
SMV
Superintendence of the Securities
Market
DECADE OF EQUAL OPPORTUNITIES FOR WOMEN AND MEN -YEAR OF THE UNIVERSALIZATION OF HEALTH
The global pandemic caused by COVID-19 and its effects; represented mainly by the declaration of the National State of Emergency, the partial or total stoppage of most economic activities, mandatory social isolation (confinement or quarantine), the restriction of certain constitutional freedoms and guarantees, border closures, shortages of goods and services, decreased demand, volatility of prices and interest rates, the absence of a vaccine and effective treatment for the disease, among others, has brought with it not only high levels of uncertainty for most Peruvian companies, but it is already possible to notice events that are affecting certain accounting measurements or estimates used when preparing financial information in accordance with International Financial Reporting Standards issued by the International Accounting Standards Board – IASB internationally in force (hereinafter, IFRS).
It must be kept in mind that according to IFRS, all or almost all economic events and significant risks must be recognized in the corresponding financial statements, measured and/or disclosed appropriately as established in IFRS themselves.
Under that premise and always within the framework of IFRS, it is deemed necessary for the Superintendence of the Securities Market - SMV to inform companies with securities registered in the Public Registry of the Securities Market – RPMV, about its view on the main considerations to be observed in the evaluation of their risks; as well as in the measurements, estimates and disclosures of their financial statements prepared in accordance with IFRS, in the face of the impact of the crisis and pandemic caused by COVID-19.
In this context, it is also necessary to highlight that the transparency of financial information in the securities market acquires vital importance for said market, and in that sense the disclosures of companies must clearly reflect the risks and uncertainties and the changes in their most important accounting estimates that each company faces, as a result of the crisis and pandemic caused by COVID-19.
In addition, it should be emphasized that the SMV, through this document, urges issuing companies and their competent governing bodies to evaluate and review in a timely and continuous manner their accounting policies and practices, especially in relation to the impact of the COVID-19 pandemic and the effects it has generated, and/or continues to cause, and to update their accounting measurements or estimates and fundamentally, their disclosures in their financial statements prepared in compliance with IFRS. Complementarily, they are urged to make the necessary disclosures or explanations in the Management Discussion and Analysis document. It should be noted that other aspects not addressed in this document may acquire importance as events occur, risks materialize or due to the particular circumstances of each entity.
The list of matters discussed in this document is illustrative and is not exhaustive or limiting, and each company, in compliance with the provisions of IFRS, must design its disclosures and provide investors and securities market participants with relevant information on the impact of COVID-19 on its financial statements.
Thus, in observance of the principle of transparency and regarding the preparation of financial statements prepared in accordance with IFRS, issuing companies with securities registered in the RPMV, in the face of the impact of the pandemic and crisis caused by COVID-19, must emphasize:
In accordance with the provisions of IAS 1, Presentation of Financial Statements, it is necessarily required that management evaluate the relevant information available up to the date of issuance of its financial statements and determine whether there are significant uncertainties regarding the company's ability to continue as a going concern, in which case it must disclose such uncertainties.
In evaluating the going concern assumption, the entity shall take into account all available information about the future, which shall cover at least the twelve (12) months following the end of the reporting period, without being limited to that period.
If, as a result of such evaluation, management concludes that it intends to liquidate the entity or to cease its activities, or that it has no realistic alternative but to do so, the going concern assumption shall not be the appropriate basis for preparing financial statements; and, therefore, it shall disclose this fact, the basis on which such financial statements have been prepared, and the reasons for such conclusion.
If the evaluation performed concludes that the going concern assumption is appropriate, despite the existence of a material uncertainty, the following information shall be disclosed in the financial statements:
1. The principal events or conditions that may give rise to significant doubts about the ability to continue as a going concern and the plans of the management or senior management to address them.
2. The material uncertainty regarding the ability to continue as a going concern as a consequence of the identified events or conditions, which may put at risk its ability to realize assets or settle liabilities in the normal course of business.
In principle, it should be borne in mind that the applicable regulatory framework establishes that your company must prepare its financial statements in full compliance with IFRS.
Within that framework and that of good Corporate Governance practices referring fundamentally to transparency of information, internal control system, risk management and regulatory compliance, it is appropriate that both the Board of Directors and Management evaluate and estimate the financial impact that the pandemic and crisis caused by COVID-19 could have, both on its financial and economic situation, and on the main projections on which it prepares its financial statements; and determine whether such impact is material for the company.
It is important that the estimates be evaluated considering both the effects of COVID-19 and the internal measures adopted or external measures such as those of support communicated by the Executive Branch.
In addition, indirect impacts through its customers, suppliers, investments in other companies, among others, must also be analyzed.
IFRS 13, Fair Value, defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date, under present market conditions. Therefore, in measuring fair value, entities must evaluate the existing market conditions and all available information that market participants would have taken into account at the measurement date. In that sense, IFRS 13 requires that, for purposes of determining fair value, the entity evaluate the information that was available or to which market participants could have had access, about the COVID-19 pandemic, at the close of the reporting period, and not afterwards.
The greater volatility observed in some markets such as oil, commodities, price and rate volatility, among others, caused by the COVID-19 pandemic, indicates significant variations in fair value, whether it is measured using relevant observable inputs (Level 1 and 2) or unobservable inputs (Level 3); however, with respect to the latter, entities are required to pay special attention to the significant estimates and judgments used in their valuation techniques, so that they reflect the conditions and assumptions used or that could have been used by market participants.
Other important references to take into account, related to fair value measurement, are those referring to the prices of securities in centralized trading mechanisms or organized markets, the risk classification of their securities, the price of commodities directly related to the company, the risk-free rate, opportunity cost indicators, economic slowdown, macroeconomic indicators with an effect on the company, among others.
They must evaluate and disclose, in accordance with the provisions of IFRS 15, what is necessary, considering that economic activity due to COVID-19 in most sectors has been paralyzed or significantly reduced, significantly affecting the demand for products and services, sales and supply channels, and thereby the sales and revenues of companies.
Due to the current circumstances, it is very likely that the company will face adverse situations due to discounts in the price of goods and services provided, returns of goods and suspension of services, penalties, reversal of revenues recognized from customer contracts; these events may have significant effects on variable consideration.
It must be taken into account in the evaluation to be performed that sales and revenues will be affected by the global COVID-19 pandemic, so they must consider recognition of revenue from those contracts only when it is probable that the customer will fulfill its obligations when they become due.
Given such circumstances, companies are required to review, and if applicable, update the accounting policy applied, considering the following aspects:
It is a change in the scope or in the price (or in both) of a contract that is approved by the parties. There is a modification of a contract when the parties approve a change that creates new enforceable rights and obligations for them in the same contract, eliminates some, or changes arise in the existing ones, paragraph 18 of IFRS 15.
The entity shall evaluate whether to account for the modification of a contract in accordance with paragraph 20 as a separate contract and, when it is not accounted for as a separate contract, in accordance with paragraph 21 of IFRS 15.
If the consideration promised in a contract includes a variable amount, the entity shall estimate the amount of the consideration to which it will be entitled in exchange for transferring the promised goods or services to the customer, in accordance with paragraph 50 of IFRS 15.
The amount of the consideration may vary due to discounts, returns, refunds, credits, price reductions, incentives, penalties or other similar items. The agreed consideration may also vary if the entity's right to receive it depends on whether or not a future event occurs, paragraph 51 of IFRS 15.
The entity shall evaluate estimating an amount of variable consideration using one of the following methods: The expected value or the most likely amount, established in paragraph 53 of IFRS 15.
The entity shall recognize as an expense the costs of wasted materials, labor or other resources to fulfill the contracts that are not reflected in the contract price, paragraph 98 b) of IFRS 15.
In addition, it shall disclose information that allows users to understand the nature, amount, timing and uncertainty of cash flows arising from revenue, paragraph 110 of IFRS 15.
IAS 36, Impairment of Assets, requires that, at the end of the reporting period, entities assess whether there are indications of impairment of the value of their non-financial assets, in which case they must perform impairment tests. It is also required that, regardless of the existence of indications of impairment, impairment tests be performed annually on goodwill and intangible financial assets with indefinite useful lives.
In Peru, the temporary cessation of operations in various sectors of the economy, the sudden decrease in demand for some products and the fall in profits of many companies are indicators of impairment, which makes it necessary for companies to evaluate subjecting their assets to impairment tests and update the assumptions and cash flow projections used in carrying out such tests, so that they reflect the effects of the pandemic.
Along the same lines, IAS 28, Investments in Associates and Joint Ventures, requires entities to assess the existence of impairment in investments in associates and joint ventures accounted for under the equity method.
IAS 2, Inventories, establishes that inventories must be measured at the lower of their cost and their net realizable value.
In this context of health emergency, in which a slowdown in inventory turnover and a general reduction in exports are observed, it represents a greater challenge for companies to make their best accounting estimates to calculate the net realizable value of their stock and, probably, many of them will have to reduce the carrying amount of their inventories to their net realizable value.
On the other hand, it is important to consider that fixed production overhead costs, such as depreciation and maintenance of production machinery, which tend to remain relatively constant, regardless of production volume, form part of the costs of inventories when production is under normal circumstances; in that sense, companies that are not at their normal production capacity must recognize such costs as expenses of the period in which they have been incurred.
It shall consider evaluating and disclosing, in accordance with the provisions of IAS 16, the effects on the financial statements of the mandatory stoppage of the company's production plants (due to the COVID-19 pandemic) and consider, to the extent applicable, the following matters:
2.5.1. The depreciation of an asset measured by the straight-line method shall be accounted for even if it is used below its normal capacity or if it has ceased to be used. Whereas, for assets measured under the depreciation method based on use (units produced), and when no production activity takes place, depreciation could be zero.
2.5.2. The suspension of capitalization of borrowing costs during the time in which the development of activities of a qualifying asset has been suspended.
2.5.3. The depreciation charged to the income statement by application of IAS 16, through the straight-line method, could differ from the depreciation expense accepted for tax purposes, generating a deferred tax.
2.5.4. The disclosure of disbursements recognized in the carrying amount of assets under construction and of purchase commitments for property, plant and equipment.
It shall consider evaluating and disclosing, in accordance with the provisions of IFRS 71, the nature and extent of the risks arising from financial instruments and the manner in which they are managed, which must contain detailed information to know their concentration and financial effects during the health crisis of the COVID-19 pandemic and how they will be mitigated by the company.
[1] IFRS 7, «Financial Instruments; disclosures» paragraph 32
The disclosures in the financial statements must provide qualitative and quantitative information on each of the risks to which the company is exposed at the end of the reporting period, mainly in relation to credit risks, liquidity risks and market risk (currency, interest rate and price).
Consideration should be given to assessing, in accordance with the provisions of IFRS 92, at the close of each reporting period, whether there is any objective evidence of a significant increase in the expected credit losses of a financial asset or a group of financial assets due to impairment of its value, as a result of one or more events occurring after the initial recognition of the asset with an impact on the estimated future cash flows in a reliable manner. Evidence of impairment of value could include, among others, indications such as debtors with proven financial difficulties, default or delinquency in debt payments of principal or interest, the probability that they will declare bankruptcy or adopt another form of reorganization.
It is likely that recent changes in national and global economic conditions have not been contemplated in the macroeconomic scenarios used in companies' expected credit loss models, hence it is necessary for companies to consider updating or incorporating new scenarios and to review the probability weightings assigned to such scenarios.
Consideration should be given to assessing, in accordance with the provisions of IFRS 93, the effects of the health crisis caused by the COVID-19 pandemic on the financial statements. As a result of interruptions in their operations, it is likely that companies will need to obtain additional financing or modify the terms of the agreements contained in existing contracts, which requires determining the current condition of the existing financial liability, in order to know whether the changes in the contractual agreements represent or not a substantial modification or potentially an extinguishment of the contract.
Consideration should be given to disclosing, in accordance with the provisions of IFRS 74, the impact on the financial statements that the COVID-19 health crisis could cause due to the breach of assumed commitments and the safeguard clauses of contracts that trigger clauses involving significant adverse changes to the company and that could have the effect of early maturities, and even the immediate enforceability of the obligation. The foregoing makes it necessary both to review long-term financial liabilities with such commitments and to keep control of their compliance or manage it, since failure to comply could place the company in extreme situations and affect the continuity as a going concern.
[2] IFRS 9 "Financial instruments", paragraph 5.5
[3] IFRS 9 "Financial instruments", paragraph 3.3
[4] IAS 7 "Financial instruments: disclosure", paragraphs 7 and B3
As a consequence of COVID-19, it is possible that many companies are renegotiating the terms of their lease contracts or certain concessions in lease payments have been agreed (rent holidays or temporary reductions). In these cases IFRS 16, Leases, requires companies to:
2.7.1. Assess whether the changes in lease payments represent a modification of the lease.
2.7.2. Recognize the aforementioned changes according to whether or not they are a modification of the lease, and
2.7.3. Disclose sufficient information to enable users to understand the impact that changes in lease payments have on the company's financial statements.
It should be mentioned in this regard that, on 24 April 2020, The International Accounting Standards Board published a draft of amendments to IFRS 16 Leases, called Exposure Draft Covid-19-Related Rent Concessions, which is open for public comment.
IAS 37, Provisions, Contingent Liabilities and Contingent Assets, defines an onerous contract as one in which the unavoidable costs of meeting the obligations it entails exceed the economic benefits expected to be received from it.
In this context of COVID-19, the standard requires an assessment of whether any of the company's current contracts have become onerous contracts, in which case the company must recognize a provision for the present obligations arising from such contracts.
IAS 37, Provisions, Contingent Liabilities and Contingent Assets, defines a restructuring as a program of action, planned and controlled by the company's management, that significantly affects the scope of the company's activities or the manner in which they will be carried out.
Due to the circumstances in which we find ourselves because of COVID-19, a company may decide to implement restructuring plans such as the closure of part of its business or a reduction of its operations, so it must take into account, for the recognition of a restructuring provision, the general recognition criteria regulated in IAS 37.
In this regard, it should be taken into account that a restructuring represents an implicit obligation (provision) for the company, provided that there is a formal detailed plan to carry out such restructuring, and a valid expectation has been created among those affected that the restructuring will be carried out.
If there is a formal and detailed restructuring plan, IAS 37 requires that the nature of the obligation and the expected timing of the outflow of economic benefits be broken down. In addition, IFRS 5, Non-current Assets Held for Sale and Discontinued Operations, requires companies to disclose information about discontinued operations that may eventually result from the restructuring.
Given the current economic crisis caused by COVID-19 and in order to preserve employment and reactivate the economy, the Executive Branch has been taking measures involving the provision of assistance or subsidies to private sector companies that meet certain requirements.
In this regard, companies should determine whether such assistance falls within the scope of IAS 20, and evaluate the accounting implications in their financial statements.
IAS 10, Events after the Reporting Period, requires the company to evaluate events occurring after the reporting period and before the date of authorization of the financial statements for publication, and determine whether such events provide evidence of situations or conditions existing at the end of the reporting period or that arose after that date.
As a result of such evaluation, the company must establish whether there are events that require adjustments to its financial statements and disclosure; or events that, even if they do not require adjustments, are material and require disclosure.
In this regard, it is important that companies evaluate the impact on their financial statements of events such as the temporary cessation of their operations and the isolation measures imposed as a result of the declaration of the National State of Emergency decreed by the Executive Branch on 15 March 2020.
If companies determine that the impact on the financial statements is material and that they do not require adjustments to their financial statements, they must disclose in notes the nature of the event and estimate its financial effects or explain, if applicable, the impossibility of making such an estimate.
IAS 34, Interim Financial Reporting, requires the company to include in its financial statements an explanation of the events and transactions that occurred since the end of the last annual period presented that are significant for understanding the changes in the entity's financial position and economic results. That standard also provides a list of events and transactions that should be disclosed, to the extent that they are significant, some of which have been addressed in this document.
Issuing companies with securities registered in the RPMV that prepare their financial information in accordance with IFRS are required to submit a Management Report comprising the Management's Analysis and Discussion, which in turn must contain the provisions of item «10.002 Management's Analysis and Discussion» of the Manual for the Preparation of Financial Information, approved by CONASEV Resolution No. 103-99-EF/94.10.
In this line, and within the framework of the requirements of truthfulness and sufficiency of financial information and the concept of transparency of information in the securities market, it is necessary to highlight that most of the IFRS referred to in this document contain specific disclosure requirements that, together with standards such as IAS 1 and IFRS 7, require companies to provide additional relevant and sufficient information about the entity's future prospects that allows users to understand the overall (current and potential) impact of COVID-19 on its financial position and financial performance.
Thus, the notes and the Management's Analysis and Discussion of the Management Report have the purpose and must be used by the aforementioned issuing companies to make all disclosures of significant matters that must be made and even more so, if they are prepared in such a way that they help a better understanding of the related financial information.
On the other hand, it is clear to everyone that within the effects of COVID-19 —such as confinement and the total and partial stoppage of companies' activities— there is a high probability that the internal control system related to the preparation of financial information of issuing companies has been affected. Indeed, certain accounting recording procedures cannot and would not have been done in the manner in which they were functioning before the pandemic or their scope is limited. Likewise, it is highly likely that the controls and risk mitigation mechanisms of such procedures could have been affected in a similar manner.
In view of this, it is noted that new risks associated with the preparation of financial information have appeared, and specifically, risks linked to the integrity and reliability of the financial information reported in accordance with IFRSs, derived mainly from the foregoing paragraph and also from situations that could be affecting the timeliness with which accounting records are made, the measurement of transactions or of the company's assets and liabilities, the nature of the transactions and the place where they are reported for the consolidation of the accounting process, remote work, among others.
Given these risks, it is necessary that the Management's Analysis and Discussion of the Management Report disclose how the company and its bodies have been managing the risks associated with the internal control system that has been operating for the preparation and reporting of the financial information disseminated to the market.
Although the Management Report must be presented together with the interim financial information, there is no legal impediment for issuing companies to disclose to the market a Management Discussion and Analysis with the explanatory information detailed in this document, the management of their business continuity plans and the additional information that the competent bodies of the issuing company consider relevant and observance of the principle of transparency of information in the securities market, which is also a good corporate governance practice.
On the other hand, it should be noted that the IASB, which issues the IFRS, various highly developed securities market authorities and organizations such as IOSCO, ESMA and others, have been issuing pronouncements and documents that may serve as guidance on the important matters to be disclosed in the financial statements.
Finally, the SMV considers it necessary to indicate that external audit firms that audit financial statements of companies with securities registered in the RPMV must consider the content of this document when carrying out their activities.
Note from RegAlert. AI assistants can read this document in full, and search 70,000+ more, through the RegAlert MCP connector (https://mcp.regalert.today/mcp). Free with an account. How to connect ChatGPT, Claude or Cursor.
RegAlert holds no document that amends or replaces this one. This is not a check that it is in force: confirm with the regulator.
“compliance with the regulatory requirements established in SMV Resolution No. 016-2015-SMV/01 and its amending norms”
“Circular No. 140-2020-SMV/11.1 has been issued to all securities issuers, through which the document entitled "Impact of the pandemic and COVID-19 crisis on the Financial Statements..." has been sent to them”
“duty to safeguard the interests of bondholders as its own, as provided in article 92 of the Securities Market Law, Legislative Decree No. 861”
More like this from SMV
SMV published 22 documents in the last 30 days. We email you each new one the day it's published.
Source: Superintendencia del Mercado de Valores (Peru) — original document · Summary generated with machine assistance and checked by an AI reviewer before publication; the authoritative text is the regulator's original document. How RegAlert works
In RegAlert: added